The global demand for Transferrin Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Transferrin refers to a blood-plasma glycoprotein, which plays an essential role in iron metabolism. It is responsible for ferric-ion delivery and seems to be crucial for most cells growing in tissue culture. It is considered an essential culture media ingredient used for cell culture-based production of therapeutic vaccines and proteins. Recombinant human transferrin is a common protein accountable for iron metabolism and transportation. It also helps in the growth and productivity of cells. Every 80kDA transferrin molecule can bear two ions of iron in the ferric form. The recombinant human transferrin activity is equal to human serum holo transferrin. It comprise of a polypeptide chain of amino acids. The recombinant human transferrin is a non-glycosylated produced in the plant and purified by exclusive chromatographic methods.
Market Dynamics
The increasing prevalence of iron deficiency anemia worldwide is driving the recombinant human transferrin market over the forecast time frame. In addition to that, rapid advancements in sequencing technology and bioinformatics contribute to the recombinant human transferrin market. The constant growing application areas of DNA sequencing techniques positively impact recombinant human transferrin market growth. Moreover, the governmental agencies high funding for research activities in the recombinant human transferrin area is likely to provide profitable growth opportunities for key players in the recombinant human transferrin market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of transferrin.
Market Segmentation
The entire transferrin market has been sub-categorized into source, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Source
- Plant-Derived Transferrin
- Blood-Derived Transferrin
By Application
- Cell Culture
- Cell Growth
- Tissue Culture
- Biotechnology
- Medicines
- Others
By End User
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for transferrin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Transferrin Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the transferrin market include Thermo Fisher Scientific, Merck, BBI Solutions, MP Biomedicals, ProSpec, Yeasen Biotech, PromoCell, Corning, InVitria, Biotium, PeproTech, Inc., Lee BioSolutions, Novoprotein, Richcore Lifesciences Pvt Ltd., ACROBiosystems. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.